Search

You searched for "ejaculating"

289 results found

All you need to know about percutaneous nephrolithotomy: supine versus prone and mini versus traditional

1 September 2014 | | URO - Endourology & Stones
Introduction Since the first percutaneous nephrolithotomy (PCNL), the technique has undergone many innovations, including modifications in positioning, miniaturisation of instruments and combination with retrograde intra-renal surgery (see Table 1 for an outline of the history of the technique). Controversy has...

LUTS update

8 January 2024 | | URO - Functional / Reconstructive Urology
Case study A 70-year-old, generally fit and well male attends your outpatient clinic. He has experienced a gradual deterioration in his voiding over the last few months. Specifically, he reports hesitancy, poor flow and nocturia. He denies visible haematuria. His...
BJUI cover image

Testosterone supplementation after prostatectomy – journey from bad to good

6 November 2020 | | URO - Andrology, URO - Urologic Oncology
The role of androgens in the pathogenesis of prostate cancer is quite complex and is not entirely clear yet. Despite several reports suggesting testosterone use is safe in patients diagnosed with prostate cancer, many clinicians are still reluctant to use...

Action Bladder Cancer UK offers grants for bladder cancer research

21 November 2024 | Charities, Awards, Conferences & Anniversaries, Research & Development
Action Bladder Cancer UK (ABC UK) is inviting applications for grants to support research into bladder cancer, encouraging projects that aim to improve bladder cancer care, treatment, or diagnosis.

Prostate cancer spit test could save the NHS £500 million a year

15 October 2024 | Research & Development
Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, thanks to a new spit test which can be taken at home. An innovative new study launched this week,...

Ketamine uropathy – an update

29 January 2020 | | URO - Functional / Reconstructive Urology
The first two case series that documented the association between urinary tract damage and recreational ketamine use were published 12 years ago [1,2]. Since then ketamine has maintained a controversial profile as an essential medication of expanding utility but with...

In conversation with Roger Kirby

3 September 2020 | URO - Core Urology
We were delighted to catch up with Roger Kirby, new President of the RSM, about his illustrious career in urology. Can you tell us a little bit about what led you into the field of urology and what have been...

The prostatic punch

1 May 2015 | | URO - Functional / Reconstructive Urology, URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the BAUS Virtual Museum of the History of Urology, this is also part of the BAUS website (www.baus.org.uk). In the last article I...

Action Bladder Cancer UK – 2019 Report

11 December 2019
ABC UK is a national charity working for bladder cancer patients. Set up in 2009 we work to raise awareness of bladder cancer and the issues faced by patients; we provide direct support for patients; we work to improve outcomes for...

In conversation with Professor Christopher Chapple

1 March 2017 | URO - Core Urology
Professor Christopher Chappel. Prof Chapple, thank you for taking the time to chat with the Urology News team. Can we start by asking about your background and how you ended up in the field of urology? Early in my career...

New ultrasound imaging technique reliably spots prostate cancer, initial patient trial reveals

16 January 2025
A groundbreaking new imaging approach developed by researchers at Heriot-Watt University has shown ‘extremely encouraging’ results in early-stage clinical trials on prostate cancer at the Western General Hospital in Edinburgh, Scotland. The ongoing clinical trial demonstrated an initial 94% sensitivity...

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

7 January 2021 | | URO - Urologic Oncology
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...